Cover Image
Market Research Report

Generics Global Industry Guide 2013-2022

Published by MarketLine Product code 251357
Published Content info 263 Pages
Delivery time: 1-2 business days
Price
Back to Top
Generics Global Industry Guide 2013-2022
Published: October 26, 2018 Content info: 263 Pages
Description

Summary

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Questions Answered:

What was the size of the global generics market by value in 2017?

What will be the size of the global generics market in 2022?

What factors are affecting the strength of competition in the global generics market?

How has the market performed over the last five years?

How large is the global generics market in relation to its regional counterparts?

Scope

  • Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.
  • For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
  • The market value is evaluated at ex-factory prices.
  • Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.
  • Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.
  • Note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.
  • All currency conversions were calculated at constant average annual 2017 exchange rates.
  • The global generics market had total revenues of $307.6bn in 2017, representing a compound annual growth rate (CAGR) of 8.2% between 2013 and 2017.
  • Market consumption volume increased with a CAGR of 1.9% between 2013 and 2017, to reach a total of 70.2% in 2017.
  • The US is the largest market in the world; it made up 33.5% of the global value in 2017. Other large markets include China, Japan, Germany, and India.
  • Reasons to buy
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
  • Leading company profiles reveal details of key generics market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume
Table of Contents
Product Code: MLIG180057-06

Table of Contents

EXECUTIVE SUMMARY 2

  • Market value 2
  • Market value forecast 2
  • Market volume 2
  • Market volume forecast 2
  • Geography segmentation 2

Introduction 20

  • What is this report about? 20
  • Who is the target reader? 20
  • How to use this report 20
  • Definitions 20

Global Generics 21

  • Market Overview 21
  • Market Data 23
  • Market Segmentation 25
  • Market outlook 26
  • Five forces analysis 28

Generics in Asia-Pacific 34

  • Market Overview 34
  • Market Data 36
  • Market Segmentation 38
  • Market outlook 39
  • Five forces analysis 41

Generics in Europe 47

  • Market Overview 47
  • Market Data 49
  • Market Segmentation 51
  • Market outlook 52
  • Five forces analysis 54

Generics in France 60

  • Market Overview 60
  • Market Data 61
  • Market Segmentation 63
  • Market outlook 64
  • Five forces analysis 66
  • Macroeconomic indicators 72

Generics in Germany 74

  • Market Overview 74
  • Market Data 75
  • Market Segmentation 77
  • Market outlook 78
  • Five forces analysis 80
  • Macroeconomic indicators 86

Generics in Italy 88

  • Market Overview 88
  • Market Data 89
  • Market Segmentation 91
  • Market outlook 92
  • Five forces analysis 94
  • Macroeconomic indicators 100

Generics in Japan 102

  • Market Overview 102
  • Market Data 103
  • Market Segmentation 105
  • Market outlook 106
  • Five forces analysis 108
  • Macroeconomic indicators 114

Generics in Australia 116

  • Market Overview 116
  • Market Data 117
  • Market Segmentation 119
  • Market outlook 120
  • Five forces analysis 122
  • Macroeconomic indicators 128

Generics in Canada 130

  • Market Overview 130
  • Market Data 131
  • Market Segmentation 133
  • Market outlook 134
  • Five forces analysis 136
  • Macroeconomic indicators 143

Generics in China 145

  • Market Overview 145
  • Market Data 146
  • Market Segmentation 148
  • Market outlook 149
  • Five forces analysis 151
  • Macroeconomic indicators 158

Generics in The Netherlands 160

  • Market Overview 160
  • Market Data 161
  • Market Segmentation 163
  • Market outlook 164
  • Five forces analysis 166
  • Macroeconomic indicators 172

Generics in Spain 174

  • Market Overview 174
  • Market Data 175
  • Market Segmentation 177
  • Market outlook 178
  • Five forces analysis 180
  • Macroeconomic indicators 186

Generics in The United Kingdom 188

  • Market Overview 188
  • Market Data 189
  • Market Segmentation 191
  • Market outlook 192
  • Five forces analysis 194
  • Macroeconomic indicators 201

Generics in The United States 203

  • Market Overview 203
  • Market Data 204
  • Market Segmentation 206
  • Market outlook 207
  • Five forces analysis 209
  • Macroeconomic indicators 215

Company Profiles 217

  • Leading Companies 217

Appendix 261

  • Methodology 261
  • About MarketLine 262

List of Tables

  • Table 1: Global generics market value: $ billion, 2013-17
  • Table 2: Global generics market volume: % of total pharma, 2013-17
  • Table 3: Global generics market geography segmentation: $ billion, 2017
  • Table 4: Global generics market value forecast: $ billion, 2017-22
  • Table 5: Global generics market volume forecast: % of total pharma, 2017-22
  • Table 6: Asia-Pacific generics market value: $ billion, 2013-17
  • Table 7: Asia-Pacific generics market volume: % of total pharma, 2013-17
  • Table 8: Asia-Pacific generics market geography segmentation: $ billion, 2017
  • Table 9: Asia-Pacific generics market value forecast: $ billion, 2017-22
  • Table 10: Asia-Pacific generics market volume forecast: % of total pharma, 2017-22
  • Table 11: Europe generics market value: $ billion, 2013-17
  • Table 12: Europe generics market volume: % of total pharma, 2013-17
  • Table 13: Europe generics market geography segmentation: $ billion, 2017
  • Table 14: Europe generics market value forecast: $ billion, 2017-22
  • Table 15: Europe generics market volume forecast: % of total pharma, 2017-22
  • Table 16: France generics market value: $ million, 2013-17
  • Table 17: France generics market volume: % of total pharma, 2013-17
  • Table 18: France generics market geography segmentation: $ million, 2017
  • Table 19: France generics market value forecast: $ million, 2017-22
  • Table 20: France generics market volume forecast: % of total pharma, 2017-22
  • Table 21: France size of population (million), 2013-17
  • Table 22: France gdp (constant 2005 prices, $ billion), 2013-17
  • Table 23: France gdp (current prices, $ billion), 2013-17
  • Table 24: France inflation, 2013-17
  • Table 25: France consumer price index (absolute), 2013-17
  • Table 26: France exchange rate, 2013-17
  • Table 27: Germany generics market value: $ million, 2013-17
  • Table 28: Germany generics market volume: % of total pharma, 2013-17
  • Table 29: Germany generics market geography segmentation: $ million, 2017
  • Table 30: Germany generics market value forecast: $ million, 2017-22
  • Table 31: Germany generics market volume forecast: % of total pharma, 2017-22
  • Table 32: Germany size of population (million), 2013-17
  • Table 33: Germany gdp (constant 2005 prices, $ billion), 2013-17
  • Table 34: Germany gdp (current prices, $ billion), 2013-17
  • Table 35: Germany inflation, 2013-17
  • Table 36: Germany consumer price index (absolute), 2013-17
  • Table 37: Germany exchange rate, 2013-17
  • Table 38: Italy generics market value: $ million, 2013-17
  • Table 39: Italy generics market volume: % of total pharma, 2013-17
  • Table 40: Italy generics market geography segmentation: $ million, 2017
  • Table 41: Italy generics market value forecast: $ million, 2017-22
  • Table 42: Italy generics market volume forecast: % of total pharma, 2017-22
  • Table 43: Italy size of population (million), 2013-17
  • Table 44: Italy gdp (constant 2005 prices, $ billion), 2013-17
  • Table 45: Italy gdp (current prices, $ billion), 2013-17
  • Table 46: Italy inflation, 2013-17
  • Table 47: Italy consumer price index (absolute), 2013-17
  • Table 48: Italy exchange rate, 2013-17
  • Table 49: Japan generics market value: $ million, 2013-17
  • Table 50: Japan generics market volume: % of total pharma, 2013-17

List of Figures

  • Figure 1: Global generics market value: $ billion, 2013-17
  • Figure 2: Global generics market volume: % of total pharma, 2013-17
  • Figure 3: Global generics market geography segmentation: % share, by value, 2017
  • Figure 4: Global generics market value forecast: $ billion, 2017-22
  • Figure 5: Global generics market volume forecast: % of total pharma, 2017-22
  • Figure 6: Forces driving competition in the global generics market, 2017
  • Figure 7: Drivers of buyer power in the global generics market, 2017
  • Figure 8: Drivers of supplier power in the global generics market, 2017
  • Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2017
  • Figure 10: Factors influencing the threat of substitutes in the global generics market, 2017
  • Figure 11: Drivers of degree of rivalry in the global generics market, 2017
  • Figure 12: Asia-Pacific generics market value: $ billion, 2013-17
  • Figure 13: Asia-Pacific generics market volume: % of total pharma, 2013-17
  • Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2017
  • Figure 15: Asia-Pacific generics market value forecast: $ billion, 2017-22
  • Figure 16: Asia-Pacific generics market volume forecast: % of total pharma, 2017-22
  • Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2017
  • Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2017
  • Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2017
  • Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2017
  • Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2017
  • Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2017
  • Figure 23: Europe generics market value: $ billion, 2013-17
  • Figure 24: Europe generics market volume: % of total pharma, 2013-17
  • Figure 25: Europe generics market geography segmentation: % share, by value, 2017
  • Figure 26: Europe generics market value forecast: $ billion, 2017-22
  • Figure 27: Europe generics market volume forecast: % of total pharma, 2017-22
  • Figure 28: Forces driving competition in the generics market in Europe, 2017
  • Figure 29: Drivers of buyer power in the generics market in Europe, 2017
  • Figure 30: Drivers of supplier power in the generics market in Europe, 2017
  • Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2017
  • Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2017
  • Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2017
  • Figure 34: France generics market value: $ million, 2013-17
  • Figure 35: France generics market volume: % of total pharma, 2013-17
  • Figure 36: France generics market geography segmentation: % share, by value, 2017
  • Figure 37: France generics market value forecast: $ million, 2017-22
  • Figure 38: France generics market volume forecast: % of total pharma, 2017-22
  • Figure 39: Forces driving competition in the generics market in France, 2017
  • Figure 40: Drivers of buyer power in the generics market in France, 2017
  • Figure 41: Drivers of supplier power in the generics market in France, 2017
  • Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2017
  • Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2017
  • Figure 44: Drivers of degree of rivalry in the generics market in France, 2017
  • Figure 45: Germany generics market value: $ million, 2013-17
  • Figure 46: Germany generics market volume: % of total pharma, 2013-17
  • Figure 47: Germany generics market geography segmentation: % share, by value, 2017
  • Figure 48: Germany generics market value forecast: $ million, 2017-22
  • Figure 49: Germany generics market volume forecast: % of total pharma, 2017-22
  • Figure 50: Forces driving competition in the generics market in Germany, 2017
  • Figure 51: Drivers of buyer power in the generics market in Germany, 2017
  • Figure 52: Drivers of supplier power in the generics market in Germany, 2017
  • Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2017
  • Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2017
Back to Top